|
Market Closed -
NYSE
16:03:33 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 264.34 USD | -0.29% |
|
+0.14% | +15.69% |
| 06:01pm | US FDA approves AbbVie's drug for Parkinson's disease | RE |
| 09-25 | ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO | RE |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABBV | Delayed | |
CBOE
| ABBV | Real-time | |
|
Tradegate
| 4AB | Real-time | |
|
Mexican S.E.
| ABBV * | End-of-day quote | |
|
Boerse Muenchen
| 4AB | Real-time | |
|
Borsa Italiana
| 1ABBV | End-of-day quote | |
|
Xetra
| 4AB | Delayed | |
|
London S.E.
| 0QCV | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 4AB | Delayed | |
|
Börse Stuttgart
| 4AB | Delayed | |
|
Swiss Exchange
| ABBV | Delayed | |
|
Wiener Boerse
| ABBV | End-of-day quote | |
|
CBOE
| 0QCV | Real-time | |
|
Santiago S.E.
| ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBVCL | End-of-day quote | |
|
Swiss Exchange
| ABBV | Delayed | |
Buenos Aires S.E.
| ABBVD | End-of-day quote | |
|
Buenos Aires S.E.
| ABBV | End-of-day quote | |
Toronto S.E.
| ABBV | Delayed | |
|
Deutsche Boerse AG
| 4AB0 | Delayed | |
Thailand S.E.
| ABBV19 | End-of-day quote | |
Thailand S.E.
| ABBV80 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 265.97 | 265.97 | 264.96 |
| Spread/Res. | -0.61% | -0.61% | -0.23% |
| Spread/Supp. | +6.25% | +16.08% | +16.08% |
| Support | 248.78 | 227.73 | 227.73 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ABBV Stock
- Charts AbbVie Inc.
Select your edition
All financial news and data tailored to specific country editions
